Form 4: Hims & Hers Health CFO Oluyemi Okupe Sells Shares Under 10b5-1 Trading Plan

Oluyemi Okupe, CFO of Hims & Hers Health, Inc., sold 9,868 shares of Class A Common Stock at an average price of $19.9627 on October 7, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 7, 2024, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., sold 9,868 shares of Class A Common Stock.
• The shares were sold at an average weighted price of $19.9627.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 31, 2024.
• Following the transaction, Okupe directly owns 195,988 shares of Hims & Hers Health, Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock sale by an executive under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under 10b5-1 plans are generally viewed as less informative.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates